DOCSLIB.ORG

View U.S. Patent No. 10082506 in PDF Format

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
View U.S. Patent No. 10082506 in PDF Format I1111111111111111 1111111111 11111 1111111111 11111 11111 11111 lll111111111111111 USO 10082506B2 c12) United States Patent (IO) Patent No.: US 10,082,506 B2 Kiessling et al. (45) Date of Patent: Sep.25,2018 (54) MICROBIAL GLYCANS AS A TARGET OF OTHER PUBLICATIONS HUMAN INTELECTIN Tsuji et al., The Journal of Biological Chemistry, 200 l; 276(26): (71) Applicant: Wisconsin Alumni Research 23456-23463. * Foundation, Madison, WI (US) Wesener et al., Nature Structural and Molecular Biology, 2015; 22(8): 603-610.* (72) Inventors: Laura L. Kiessling, Madison, WI (US); Blixt et al., "Printed covalent glycan array for ligand profiling of Darryl A. Wesener, Madison, WI (US); diverse glycan binding proteins," Proc Natl Acad Sci USA, Kittikhun Wangkanont, Bangkok (TH) 101(49):17033-17038, 2004. Datta et al., "Identification of novel genes in intestinal tissue that are (73) Assignee: Wisconsin Alumni Research regulated after infection with an intestinal nematode parasite," Foundation, Madison, WI (US) Infect. Immun., 73(7):4025-4033, 2005. French et al., "Up-regulation of intelectin in sheep after infection ( *) Notice: Subject to any disclaimer, the term ofthis with Teladorsagia circumcincta," Int. J Parasitol., 38(3-4):467- patent is extended or adjusted under 35 475, 2008. U.S.C. 154(b) by O days. Kincaid et al., "Virtual screening for UDP-galactopyranose mutase ligands identifies a new class of antimycobacterial agents," ACS (21) Appl. No.: 14/933,891 Chem. Biol., 10:2209-2218, 2015. Nassau et al., "Galactofuranose biosynthesis in Escherichia coli (22) Filed: Nov. 5, 2015 K-12: identification and cloning ofUDP-galactopyranose mutase ," J Bacterial, 178(4):1047-1052, 1996. (65) Prior Publication Data Pedersen and Turco, "Galactofuranose metabolism: a potential target for antimicrobial chemotherapy," Cell Mo! Life Sci, 60(2):259- US 2016/0131649 Al May 12, 2016 266, 2003. Pemberton et al., "Proteomic analysis of mouse jejuna! epithelium Related U.S. Application Data and its response to infection with the intestinal nematode, Trichinella (60) Provisional application No. 62/075,369, filed on Nov. spiralis," Proteomics, 4(4):1101-1108, 2004. Tefsen et al., "Galactofuranose in eukaryotes: aspects ofbiosynthe­ 5, 2014. sis and functional impact," Glycobiology, 22:456-469, 2012. Voehringer et al., "Nippostrongylus brasiliensis: identification of (51) Int. Cl. intelectin-1 and -2 as Stat6-dependent genes expressed in lung and GOIN 33/53 (2006.01) intestine during infection," Exp Parasitol, 116:458-466, 2007. C12Q 1168 (2018.01) Wesener et al., "Recognition ofmicrobial glycans by human intelectin- GOIN 33/554 (2006.01) 1," Nature Structural & Molecular Biology, 22(8):603-613, and GOIN 33/569 (2006.01) Supplementary Information, 2015. C07K 141705 (2006.01) Wesener et al., "UDP-galactopyranose mutase in nematodes ," C07K 14147 (2006.01) Biochemistry, 52:4391-4398, 2013. C07K 7164 (2006.01) A61K 38/00 (2006.01) * cited by examiner Cl2Q 1/689 (2018.01) Primary Examiner - Gary B Nickol (52) U.S. Cl. Assistant Examiner - Lakia J Jackson-Tongue CPC .......... GOIN 33/56911 (2013.01); C07K 7164 (2013.01); C07K 1414726 (2013.01); C07K (74) Attorney, Agent, or Firm - Parker Highlander, 1417056 (2013.01); GOIN 33/56961 (2013.01); PLLC A61K 38/00 (2013.01); C07K 2319/00 (57) ABSTRACT (2013.01); Cl2Q 1/689 (2013.01); GOIN 33/56944 (2013.01); GOIN 2333/705 The present disclosure provides for methods of diagnosing (2013.01) and treating bacterial infections. Human Intelectin 1 (hlntL- (58) Field of Classification Search 1) has been shown to bind selectively to glycan components None on bacteria including Streptococcus pneumonia, Proteus See application file for complete search history. mirabilis, Proteus vulgaris, Klebsiella pneumonia and Yers­ inia pestis. This interaction can be targeted to identify, purify (56) References Cited and therapeutically target such organisms. U.S. PATENT DOCUMENTS 10 Claims, 35 Drawing Sheets (30 of 35 Drawing Sheet(s) Filed in Color) 7,312,197 B2 * 12/2007 Gong ................... C07K 14/575 514/15.7 Specification includes a Sequence Listing. U.S. Patent Sep.25,2018 Sheet 1 of 35 US 10,082,506 B2 A Bo,o. OR 00,..... -~ ' fl·-L"'-lff OH OH ,-::, ' [l~3alp p-(~~lacfofwf"<~lK)~3 ~ 0 l~i. !P,;t,:i;;s, ;.io---., .,....61Y{ d ...ix Q, t "'6 01 / .i";:; H6 1< it 02:;. C UgaM (>-Oalactofuranos,s, BS± 14 S.O,t1.3 ri-G,ilaciopyrar-.o~s r,,1:i, n.d. ·in-;:: ·w- 1 ·Hr~: j\-Rfor,se n.d. n.d. !_h!ntL-iJ {M) D Biotin j\.-Ribo~ :-onn jh.:r~t-1! (::::)?."!t.•:.:- <,;• g l!:l> .il 5 ...... ). -~; $ -(:.C,~) i,; £ ~~()- ...... (U FIGS.1A-D U.S. Patent Sep.25,2018 Sheet 2 of 35 US 10,082,506 B2 A t~n:J. i :>:n,JY.!~~ w C:-:-:·r:~sxfat:H i<1t f ·urv.:tr>n~: G:y-:::Jfr)-:rs t=· .• uuuuuuuuuuuuuuuuuuu ~... l.arr:nr.al~~ 5 f.:Jy:.:;2.: f,,_::a:1 .• uuuuuuuuuuuuuuuu {~~,.... , --,--;.~-, --1<-l)--,--~;::.-· --~~.l-,--;-:!:(....,--:u-· ,--}-•.i;--• --.i-ll-~-~-.i;--• --~u-·,--1-&.-1--d:"">-., tH.r-n\.t1k;;f1J Glyi;~ll': NH:-nt~!'f ,t~:l~l i~ ..,/' // ,/ ~,:m,#;.,0.JC;il>:i¥..t,,si B S t¥~:-:.r.':b'x:X.:S.!--!y'::,P.'1';:( l? lf:ZfStti:t"❖ 0~4:.t~.., .s ;:g:-r,:y:'i('.i'&X:f :y?-:- ~-, ;;...(X:;-:f:.~:J:-l­ p .::.,,,:.-,:.t,..:i;;; Of:-1~, :':-fo ~ ;:e~,sw .. .. .. ... .. .·· ...... :-;.-.. ~'. ::vfg-;:,.•* (:?:-'l:=:, :~-st. ❖ !~" K ::.•nt:::.::·t,;:Jw: (.:t.~ OP:1 .,. ,,.. ),. ;.~-.--~-.;:.·:... ~:) ft: ~Y-1:xr,,~o.x«~:- ();?;❖: (:f'::3 ~ ···:-:,:.-.~....:~ ':i{i\,,x,, Y. .!X'.:!i:i i\U:.'.S!':{H ~ ,f._Hm! -.:/ :~ !'!. ::,_,.~~::;:Yl<.V:,S.:X~ 01 ~ ~~$ _,. i::~KG· ::-.l 10 '( .,,;,:,ti; WA-3!' :..,:-·a-H*P-°<m' :-:<~ :i '{ :':'of!>~i;~ il:M~~«:{H}·S~~ ·, ·-,.;;/ I .l I ·;2 '/ ;x:.::f:-:: 1•<M2-rot rt~ ..sw❖;.* · <l ---!,-"--_..,.""";,,.,"',-""-""'""'""'"',-=""'...._,.,_ __ _. H :~w~xr.,:ox«❖:-{y":x,:J.0< ~~ :3! :{(: ~-i~ ~3)) /.X> :i:(: 14 Y.1~:i:":;:~.. Y. ✓.::J.~·::H,f-.iXl'-•:f: •:~:~.-~·Vl i:y !mm>-:1%re:l (;l'tC,:'1 N:.x&.,,s- fa )' ~N:: 1:H)i~b . •~.-:..-:.1).)'• FIGS. 2A-D U.S. Patent Sep.25,2018 Sheet 3 of 35 US 10,082,506 B2 A B FIGS. 3A-B U.S. Patent Sep.25,2018 Sheet 4 of 35 US 10,082,506 B2 Inhibition of hh1tL-·1 Binding S to rt:.._ .. ,_~ OJ! roE 06 ·-J c 1: 0.4 0 C (l.2 .0 FIG.4 U.S. Patent Sep.25,2018 Sheet 5 of 35 US 10,082,506 B2 A :':'®':':-::;,.,,_,,,:lit:::: \~ K! ~ K>,i ~ ~ )/~):JH~ t Yi i ~' • tc: l~t 4 ~3 \~>- -:.,{~ .-~~ ~:.:.~~ ~~i1 ·:t ~:..:;>t\1~::.:;.•\lJ:.:.(,'?i').tt!::\N :::c·tK:?l'.fC''- \':P ·q;:o:~ \:'Ki~KiH(:•":-A3ilUn ':-/ :t .> :.}.:\:i:t:i:fY.li,U<f:: ·:-·~V,.ff<::t·•\A~:~:;.·~ 1 ~l!Mi\~~ii::1fA{< 1•:, ,;.::Pi~ \~·;.;;-~~:f!~:·ii'•.f~(~f;-:.:r:i" t~! r,{: ·~l ~! ;~t ~~l ~ :: ;:qv.~l :.:.(.( ';!i~~:: N U)B~l~W~J-:q t \ -:...~ ;:>:~ \i Ki ~K~~ !·:! ~:AmlU '{~ ·.,/ n: .. 1 Y.l:J!h::;:· :M·;,.\lXYt'\.-t~: :~; jf:Jm:.:,,;;_;r-;•.,_.::i:.. '-.,>f•:~ '-.\K: ddH::~KN.)H:,; ¥:i . ~ f r..:w~\tjL · ~- ',l\,: (: ~ :: l \i --\~.X.(,;~~ .. {}V If\ yq,:: ¼'~IN:: ft ;\~'I : \ ~ i :=·:{ E Kl ~ tJ f :: : ;\_:'1,(_,i!U {H {:,(, ·~I. · .... · · · V.i '·, ir·-.: :: :: t /\! AS j.: ;.1:...H:·\-., ..... ; \~-~\I-...: ::..Kt ;.~ l; f>H ~ A:_'.:~ t=: (,N:'it!N':.i :....:~\(-.-./•,:-' ::<.. i)~-tt~'T"t.'ft~"' Xf a~v.::~.!~/~P-~}(. l n & :{ ~::::!1!:,:;:::ll,:;:,:::UJitJJJitU ..-:tltlJi.itJJJit ::~:::::::::::~:::'111!:::-:::-::0<~:::::::::AtJJitJJii.itiiU:::::t11!$:::::::~:::it!Ji.i.itJitJJJU:::t!'l!'Z:ll,m~ : t--::: Ni:.~ l 'f~}'. !· t~W: \ht,~~:..•~:: v,.\",,Vtif N('t)t:.!,<..::~.<.: v~.UKW\\t:t:<.. m.;~.::n.'~ U.X.d·htttf•H'til ! (,\ ..'\! ,\At ·::::.:rKm'V('fUl:.)fi.KK~ ' ' ~~3~3 11:~ !.?0 ~::~~ ~.~f" L:~1 ~;·;.~~ id~ ':80 ·:l : K: t N.;_.~ l )' :}: f ;_ :.)~~: \{.,{.,,;_.~_¼·: l Vl'... '.¥J.:I ~ii~:~U((l \':..,GH>''i\\~}~J ... ,\Kf'.. V,P} ~ .. m.Nt.-'1\~'tNl I \,··~Al t\ld \:_::::n:m~~.rnnq.:w,rn :/,/ r,: 'l ,:(: ·;l '. ~; ~~~: t~·f 3; ~ ~ !.;!;; t~::}~:.; ~ ~:1::~;.;; :~~~-:~;-. ~ ~~:;;;:~ ~l]~:t.::~~;:;~·:;; !:~~~~::~~;~ i! \\~: ;~1 ~ ~;_;;;;,f~i/:~::;: ~{~~{~i I;~: ': I. : i,:: l nLV j '( ~; H. :~~: ·: A~i(,:_,t,l;: : '.{[>'•: Vtif ~N:. ::{(,::H_ : V~1tiKW'-. ~-~J.;~~JN~::'\l 1)'H ~,:J~.N)\,.::,~,r(.fB ! (.'-.:,: (_.{\ f ··:::::rKtW:.., '( ! H HH"d M ·;[ : I{: t N-:., ~ l )' :) ; r ~ :.1~1: \(,{.,-:.,<¼·: l Vl'.. '. l HI mw::.cKt l t (,GEs'ii\ ~:.£.i~/.,f,ff(P',.:)YP} <.,Ut~{?t'i\X:rJ..: l I ,:;;!:,: AA~ \t::::YUiP<YfU 3!.?,{l{~rn 0 \c ·:l : ,\: : PL: ~- 'f Q '. ~ ('.?~?: ·:NG(,(,:,!;: : \fA'•: Vt:f ~r-e--1H .. ~~<.: v~:tiKW\: Q\~~JN~H iJNn 1:,0{,N)\M.f( Al!(.~ ::-i (.,{\} ': ::::rKm·(. 't fB B :"'i.K~~ ;:;:;:;:~;:;:,:ll!:»ll!:llll!::#::,:;:;~:::llll!:,:;m;:;:::;:,;:;:ll,:;:~:;::::#:::~;:,_,,,,~;:;:::;-:;:,::11!$:::-::ll,:;:-;:;~:::::::;m::::;:,#::,'111! ·::!.~!:1:~·r~.~tHr~}~~?.~:~.?:J.;;t·1~ ::~?.~·\;ft!.:?~!.~.~:_;:_i:t=~t~:~~::;it~~:~1??!!!:_tt~·~:~.~-!:!::i!):{;r~\~·.!.!.?t;pJ!~i.!:r~:::.. 1:}7-0 .; I .. , l wn·,·1·~x--.}•~l,.~:H'iPr-,'·,f l x~!~ i \H;,',: : (n l :.(-:t..:: l-": Y{~k, ¥!'\•iU'{,H,;;::: w:: n~:.i·',d :~v:JYiH :,::.•·niK u\(' Yr',,j)~'f,:.?i-:i· i·;: ~:.: O}!j / '{/ ·:t ..., t\:cHYV·~~ ... ;~~li)ihH\f~-..:,t t ;.;_y,~ ( r-; u..:: Qt~l (.nN; :! i,, t 'i\tKYl'V!-~ '(9.'-,u,.:,: ~~M·:w.::~~, t (:·vvnH \,L:.;<;t:.ku.::'(''\l>Y(,:.,:·:~: i VAL! V(J /I,{~ I~ i · i I. ',):. M!V~·-..;:-;,,-.,}•t H~?iEK ~:~,t l x ti~ i I f •-:~ ! {}Hf (.H~: l d YKKn'YK H,l hi(\ w:: UNt;,::·At :}v:JY1H (,:_;.'\H.}i. i :f,, "! Y P~F{,(,!-?:<: l Ud: ~·~(!_f l ::; ::{; -~f ·, t::CH\t!-·~\: ... l'I ii! ,Hdrr1·-.-... t t ~·n; i ! ti,: : -:it:.t :.. nfo;: i i,t 1-i.~K)TVk '({_,j f,Kf id m~:.::·,,: )'\.
Load more

Recommended publications
  • Bovine Intelectin 2 Expression As a Biomarker of Paratuberculosis Disease Progression
    animals Article Bovine Intelectin 2 Expression as a Biomarker of Paratuberculosis Disease Progression Cristina Blanco Vázquez 1 , Ana Balseiro 2,3 , Marta Alonso-Hearn 4, Ramón A. Juste 4 , Natalia Iglesias 1, Maria Canive 4 and Rosa Casais 1,* 1 Center for Animal Biotechnology, Servicio Regional de Investigación y Desarrollo Agroalimentario (SERIDA), 33394 Deva, Spain; [email protected] (C.B.V.); [email protected] (N.I.) 2 Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad de León, 24071 León, Spain; [email protected] 3 Departamento de Sanidad Animal, Instituto de Ganadería de Montaña (CSIC-Universidad de León), Finca Marzanas, Grulleros, 24346 León, Spain 4 Department of Animal Health, NEIKER-Basque Institute for Agricultural Research and Development, Basque Research and Technology Alliance (BRTA), Parque Científico y Tecnológico de Bizkaia, P812, E-48160 Derio, Spain; [email protected] (M.A.-H.); [email protected] (R.A.J.); [email protected] (M.C.) * Correspondence: [email protected] Simple Summary: The potential of the bovine intelectin 2 as a biomarker of Mycobacterium avium subsp. paratuberculosis infection was investigated using quantitative immunohistochemical analysis of ileocecal valve samples of animals with increasing degrees of lesion severity (focal, multifocal and diffuse histological lesions) and control animals without detected lesions. Significant differences were observed in the mean number of intelectin 2 immunolabelled cells between the three histopathological types and the control. Specifically, the mean number of intelectin 2 labelled cells was indicative Citation: Blanco Vázquez, C.; of disease progression as the focal group had the highest number of intelectin 2 secreting cells Balseiro, A.; Alonso-Hearn, M.; Juste, followed by the multifocal, diffuse and control groups indicating that intelectin 2 is a good biomarker R.A.; Iglesias, N.; Canive, M.; Casais, for the different stages of Mycobacterium avium subsp.
    [Show full text]
  • Capture of Heat-Killed Mycobacterium Bovis Bacillus Calmette-Guérin By
    Glycobiology vol. 19 no. 5 pp. 518–526, 2009 doi:10.1093/glycob/cwp013 Advance Access publication on January 29, 2009 Capture of heat-killed Mycobacterium bovis bacillus Calmette-Guerin´ by intelectin-1 deposited on cell surfaces Shoutaro Tsuji1,2,3, Makiko Yamashita2, is associated with mannan-binding-lectin-associated serine pro- Donald R Hoffman4, Akihito Nishiyama2, teases (MASPs) in serum and is an initiator of the lectin pathway Tsutomu Shinohara2, Takashi Ohtsu3, and of the complement system (Endo et al. 2006). Pulmonary surfac- Downloaded from https://academic.oup.com/glycob/article/19/5/518/1988147 by guest on 30 September 2021 Yoshimi Shibata2 tant protein A, a collectin, functions as an opsonin using the C1q 2Biomedical Sciences, Florida Atlantic University, Boca Raton, FL 33431, receptor or the surfactant protein A receptor SP-R210 (Kuroki USA; 3Division of Cancer Therapy, Kanagawa Cancer Center Research et al. 2007). L-Ficolin in serum is also an opsonin (Matsushita Institute, Kanagawa 241-0815, Japan; and 4Pathology and Laboratory et al. 1996) and a complement activator associated with MASPs Medicine, Brody School of Medicine at East Carolina University, Greenville, (Endo et al. 2006). These observations suggest that many animal NC 27834, USA lectins in extracellular fluid can enhance phagocytosis and con- Received on November 12, 2008; revised on January 25, 2009; accepted on tribute to innate immunity against pathogenic microorganisms. January 27, 2009 Intelectin is a soluble protein secreted into extracellular fluid (Tsuji et al. 2001). Mammalian intelectin is present in the intesti- Intelectin is an extracellular animal lectin found in chor- nal lumen (Wrackmeyer et al.
    [Show full text]
  • Extensive Variation in the Intelectin Gene Family in Laboratory and Wild Mouse Strains Faisal Almalki1,2,6, Eric B
    www.nature.com/scientificreports OPEN Extensive variation in the intelectin gene family in laboratory and wild mouse strains Faisal Almalki1,2,6, Eric B. Nonnecke3,6, Patricia A. Castillo3, Alex Bevin‑Holder1, Kristian K. Ullrich4, Bo Lönnerdal5, Linda Odenthal‑Hesse4, Charles L. Bevins3* & Edward J. Hollox1* Intelectins are a family of multimeric secreted proteins that bind microbe‑specifc glycans. Both genetic and functional studies have suggested that intelectins have an important role in innate immunity and are involved in the etiology of various human diseases, including infammatory bowel disease. Experiments investigating the role of intelectins in human disease using mouse models are limited by the fact that there is not a clear one‑to‑one relationship between intelectin genes in humans and mice, and that the number of intelectin genes varies between diferent mouse strains. In this study we show by gene sequence and gene expression analysis that human intelectin‑1 (ITLN1) has multiple orthologues in mice, including a functional homologue Itln1; however, human intelectin‑2 has no such orthologue or homologue. We confrm that all sub‑strains of the C57 mouse strain have a large deletion resulting in retention of only one intelectin gene, Itln1. The majority of laboratory strains have a full complement of six intelectin genes, except CAST, SPRET, SKIVE, MOLF and PANCEVO strains, which are derived from diferent mouse species/subspecies and encode diferent complements of intelectin genes. In wild mice, intelectin deletions are polymorphic in Mus musculus castaneus and Mus musculus domesticus. Further sequence analysis shows that Itln3 and Itln5 are polymorphic pseudogenes due to premature truncating mutations, and that mouse Itln1 has undergone recent adaptive evolution.
    [Show full text]
  • And Its Natural Deletion in C57BL/10 Mice of a Novel Goblet Cell Lectin
    Innate BALB/c Enteric Epithelial Responses to Trichinella spiralis: Inducible Expression of a Novel Goblet Cell Lectin, Intelectin-2, and Its Natural Deletion in C57BL/10 Mice This information is current as of September 23, 2021. Alan D. Pemberton, Pamela A. Knight, John Gamble, William H. Colledge, Jin-Kyu Lee, Michael Pierce and Hugh R. P. Miller J Immunol 2004; 173:1894-1901; ; doi: 10.4049/jimmunol.173.3.1894 Downloaded from http://www.jimmunol.org/content/173/3/1894 References This article cites 26 articles, 6 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/173/3/1894.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 23, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Innate BALB/c Enteric Epithelial Responses to Trichinella spiralis: Inducible Expression of a Novel Goblet Cell Lectin, Intelectin-2, and Its Natural Deletion in C57BL/10 Mice1 Alan D.
    [Show full text]
  • The Two Channel Catfish Intelectin Genes Exhibit Highly Differential
    ARTICLE IN PRESS Developmental and Comparative Immunology (2008) 32, 693–705 Available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/devcompimm The two channel catfish intelectin genes exhibit highly differential patterns of tissue expression and regulation after infection with Edwardsiella ictaluri Tomokazu Takanoa, Zhenxia Shaa,b, Eric Peatmana, Jeffery Terhunea, Hong Liua, Huseyin Kucuktasa, Ping Lia, Eva-Stina Edholmc, Melanie Wilsonc, Zhanjiang Liua,Ã aThe Fish Molecular Genetics and Biotechnology Laboratory, Department of Fisheries and Allied Aquacultures and Program of Cell and Molecular Biosciences, Aquatic Genomics Unit, Auburn University, Auburn, AL 36849, USA bKey Lab For Sustainable Utilization of Marine Fisheries Resources, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao 266071, China cDepartment of Microbiology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA Received 17 July 2007; received in revised form 2 October 2007; accepted 16 October 2007 Available online 26 November 2007 KEYWORDS Summary Intelectin; Intelectins (IntL) are Ca2+-dependent secretory glycoproteins that play a role in the innate Catfish; immune response. The mammalian IntL is also known as lactoferrin receptor (LfR) that is Fish; involved in iron metabolism. The objective of this study was to characterize the intelectin Infection; genes in both channel catfish and blue catfish, to determine their genomic organization Innate immunity; and copy numbers, to determine their patterns of tissue expression, and to establish if Genome they are involved in defense responses of catfish after bacterial infection. Two types of IntL genes have been identified from catfish, and IntL2 was completely sequenced.
    [Show full text]
  • Omentin Activates AMP-Activated Protein Kinase and Plays a Role in Energy Metabolism and Immune Response
    Omentin Activates AMP-activated Protein Kinase and Plays a Role in Energy Metabolism and Immune Response Item Type dissertation Authors Yu, Daozhan Publication Date 2011 Abstract Obesity is a risk factor for type 2 diabetes, cardiovascular diseases, and other diseases as well. It has been recognized that adipose tissue is an active endocrine organ that secrets many adipokines to regulate energy metabolism and inflammation. Ou... Keywords AMPK; fatty acid oxidation; omentin; AMP-Activated Protein Kinases; Diabetes Mellitus, Type 2; Inflammation; Insulin Resistance Download date 24/09/2021 17:49:22 Link to Item http://hdl.handle.net/10713/542 Abstract Title of Dissertation: Omentin Activates AMP-activated Protein Kinase and Plays a Role in Energy Metabolism and Immune Response Name of Candidate: Daozhan Yu ，Doctor of Philosophy, 2011 Dissertation Directed By: Da-Wei Gong, M.D., Ph.D. Associate Professor of Medicine Division of Endocrinology, Diabetes and Nutrition University of Maryland, Baltimore Obesity is a risk factor for type 2 diabetes, cardiovascular diseases, and other diseases as well. It has been recognized that adipose tissue is an active endocrine organ that secrets many adipokines to regulate energy metabolism and inflammation. Our group has identified omentin as among the first omental fat-specific adipokine in humans and has shown that omentin can enhance insulin-mediated glucose transport and AKT phosphorylation in adipocytes. Here, I have further characterized the role of omentin in metabolism and inflammation. In this study, I first expressed omentin protein in High-Five insect cell expression system and then purified it with a galactose-conjugated affinity column. In C2C12 myocytes, omentin increases AMP-activated protein kinase (AMPK) phosphorylation, which is known to be important for energy metabolism.
    [Show full text]
  • Strain-Specific Copy Number Variation in the Intelectin Locus on the 129
    Lu et al. BMC Genomics 2011, 12:110 http://www.biomedcentral.com/1471-2164/12/110 RESEARCHARTICLE Open Access Strain-specific copy number variation in the intelectin locus on the 129 mouse chromosome 1 Zen H Lu, Alex di Domenico, Steven H Wright, Pamela A Knight, C Bruce A Whitelaw, Alan D Pemberton* Abstract Background: C57BL/6J mice possess a single intelectin (Itln) gene on chromosome 1. The function of intelectins is not well understood, but roles have been postulated in insulin sensitivity, bacterial recognition, intestinal lactoferrin uptake and response to parasites and allergens. In contrast to C57BL/6J mice, there is evidence for expansion of the Itln locus in other strains and at least one additional mouse Itln gene product has been described. The aim of this study was to sequence and characterise the Itln locus in the 129S7 strain, to determine the nature of the chromosomal expansion and to inform possible future gene deletion strategies. Results: Six 129S7 BAC clones were sequenced and assembled to generate 600 kbp of chromosomal sequence, including the entire Itln locus of approximately 500 kbp. The locus contained six distinct Itln genes, two CD244 genes and several Itln- and CD244-related pseudogenes. It was approximately 433 kbp larger than the corresponding C57BL/6J locus. The expansion of the Itln locus appears to have occurred through multiple duplications of a segment consisting of a full-length Itln gene, a CD244 (pseudo)gene and an Itln pseudogene fragment. Strong evidence for tissue-specific distribution of Itln variants was found, indicating that Itln duplication contributes more than a simple gene dosage effect.
    [Show full text]
  • Human Intelectin-1 (ITLN1) Genetic Variation and Intestinal Expression
    www.nature.com/scientificreports OPEN Human intelectin‑1 (ITLN1) genetic variation and intestinal expression Eric B. Nonnecke1*, Patricia A. Castillo1,12, Amanda E. Dugan2, Faisal Almalki3,13, Mark A. Underwood4, Carol A. De La Motte5, Weirong Yuan6, Wuyuan Lu6,14, Bo Shen7,15, Malin E. V. Johansson8, Laura L. Kiessling2,9,10, Edward J. Hollox3, Bo Lönnerdal11 & Charles L. Bevins1* Intelectins are ancient carbohydrate binding proteins, spanning chordate evolution and implicated in multiple human diseases. Previous GWAS have linked SNPs in ITLN1 (also known as omentin) with susceptibility to Crohn’s disease (CD); however, analysis of possible functional signifcance of SNPs at this locus is lacking. Using the Ensembl database, pairwise linkage disequilibrium (LD) analyses indicated that several disease‑associated SNPs at the ITLN1 locus, including SNPs in CD244 and Ly9, were in LD. The alleles comprising the risk haplotype are the major alleles in European (67%), but minor alleles in African superpopulations. Neither ITLN1 mRNA nor protein abundance in intestinal tissue, which we confrm as goblet‑cell derived, was altered in the CD samples overall nor when samples were analyzed according to genotype. Moreover, the missense variant V109D does not infuence ITLN1 glycan binding to the glycan β‑D‑galactofuranose or protein–protein oligomerization. Taken together, our data are an important step in defning the role(s) of the CD‑risk haplotype by determining that risk is unlikely to be due to changes in ITLN1 carbohydrate recognition, protein oligomerization, or expression levels in intestinal mucosa. Our fndings suggest that the relationship between the genomic data and disease arises from changes in CD244 or Ly9 biology, diferences in ITLN1 expression in other tissues, or an alteration in ITLN1 interaction with other proteins.
    [Show full text]
  • Carbohydrate and Bacterial Binding Specificity of Human Intelectin-1
    Carbohydrate and Bacterial Binding Specificity of Human Intelectin-1 By Christine R. Isabella M.S. Biochemistry University of Wisconsin – Madison, 2017 B.S. Molecular and Cellular Biology University of Puget Sound, 2012 SUBMITTED TO THE DEPARTMENT OF CHEMISTRY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN CHEMISTRY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY February 2021 Ó 2021 Massachusetts Institute of Technology. All Rights Reserved. Signature of Author: _____________________________________________________________ Department of Chemistry January 11, 2021 Certified By: ___________________________________________________________________ Laura L. Kiessling Novartis Professor of Chemistry Thesis Supervisor Accepted By: ___________________________________________________________________ Adam P. Willard Associate Professor of Chemistry Chair, Department Committee on Graduate Students 1 This doctoral thesis has been examined by a committee of professors from the Department of Chemistry as follows: Barbara Imperiali _______________________________________________________________ Thesis Committee Chair Class of 1922 Professor of Biology and Chemistry Laura L. Kiessling _______________________________________________________________ Thesis Supervisor Novartis Professor of Chemistry Ronald T. Raines ________________________________________________________________ Thesis Committee Member Roger and Georges Firmenich Professor of Natural Products Chemistry Eric J. Alm ____________________________________________________________________
    [Show full text]
  • Identification and Characterization of a Novel Intelectin in the Digestive Tract
    Developmental and Comparative Immunology 59 (2016) 229e239 Contents lists available at ScienceDirect Developmental and Comparative Immunology journal homepage: www.elsevier.com/locate/dci Identification and characterization of a novel intelectin in the digestive tract of Xenopus laevis Saburo Nagata Department of Chemical and Biological Sciences, Faculty of Science, Japan Women's University, Mejirodai 2-8-1, Bunkyoku, Tokyo 112-8681, Japan article info abstract Article history: The intelectin (Intl) family is a group of secretory lectins in chordates that serve multiple functions, þ Received 9 December 2015 including innate immunity, through Ca2 -dependent recognition of carbohydrate chains. Although six Received in revised form Intl family lectins have so far been reported in Xenopus laevis, none have been identified in the intestine. 3 February 2016 Using a monoclonal antibody to the Xenopus embryonic epidermal lectin (XEEL or Intl-1), I identified Accepted 3 February 2016 cross-reactive proteins in the intestines. The proteins were purified by affinity chromatography on a Available online 5 February 2016 galactose-Sepharose column and found to be oligomers consisting of N-glycosylated 39 kDa and 40.5 kDa subunit peptides. N-terminal amino acid sequencing of these peptides, followed by cDNA cloning, Keywords: fi e Lectin identi ed two novel Intls (designated Intl-3 and Intl-4) that showed 59 79% amino acid identities with Omentin known Xenopus Intl family proteins. From the amino acid sequence, immunoreactivity, and properties of Bacterial lipopolysaccharide (LPS) the recombinant protein, Intl-3 was considered the intestinal lectin identified by the anti-XEEL antibody. Goblet cells The purified Intl-3 protein could potentially bind to Escherichia coli and its lipopolysaccharides (LPS), and þ Innate immunity to Staphylococcus aureus and its peptidoglycans, depending on Ca2 .
    [Show full text]
  • Expression of Intelectin-1 in Bronchial Epithelial Cells of Asthma Is
    Watanabeet al. Allergy Asthma Clin Immunol (2017) 13:35 DOI 10.1186/s13223-017-0207-8 Allergy, Asthma & Clinical Immunology RESEARCH Open Access Expression of intelectin‑1 in bronchial epithelial cells of asthma is correlated with T‑helper 2 (Type‑2) related parameters and its function Taiji Watanabe1, Kazuyuki Chibana1*, Taichi Shiobara1, Rinna Tei1, Ryosuke Koike1, Yusuke Nakamura1, Ryo Arai1, Yukiko Horigane1, Yasuo Shimizu1, Akihiro Takemasa1, Takeshi Fukuda2, Sally E. Wenzel3 and Yoshiki Ishii1 Abstract Background: Intelectin-1 (ITLN-1) is secreted by intestinal goblet cells and detectable in blood. Its expression is increased in IL-13-overexpressing mouse airways. However, its expression and function in human airways is poorly understood. Methods: Distal and proximal bronchial epithelial cells (BECs) were isolated from bronchoscopic brushings of disease control (D-CON), COPD, inhaled corticosteroid-treated asthma (ST-Asthma) and inhaled corticosteroid-naïve asthma (SN-Asthma) patients. ITLN-1 mRNA expression in freshly isolated BECs, primary cultured BECs with or without IL-13 and inhibition efects of mometasone furoate (MF) were investigated by quantitative real-time PCR (qPCR). Correla- tions between ITLN-1 mRNA and Type-2 related parameters (e.g. FeNO, IgE, iNOS, CCL26, periostin and DPP4 mRNA) were analyzed. ITLN-1 protein distribution in asthmatic airway tissue was assessed by immunohistochemistry. Bron- chial alveolar lavage (BAL) and serum ITLN-1 protein were measured by ELISA. The efect of recombinant human (rh) ITLN-1 on stimulated production of CXCL10 and phospho(p)-STAT1 expression examined in lung fbroblasts. Results: ITLN-1 mRNA was expressed in freshly isolated BECs and was correlated with Type-2 related parameters.
    [Show full text]